Semnur Pharmaceuticals, Inc.
SMNR
$9.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | -15,174.67% | -50.23% | -16.94% | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 117,708.40% | 29.35% | -20.83% | ||
| Change in Net Operating Assets | 794.69% | 559.77% | 4,147.06% | ||
| Cash from Operations | -895.15% | 167.17% | 52.94% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -- | -- | ||
| Total Debt Issued | 468.80% | 5.53% | 344.49% | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -244.01% | -81.58% | -- | ||
| Cash from Financing | 1,082.27% | -155.84% | -53.06% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -37.50% | 1,060.00% | 0.00% | ||